These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19922488)

  • 1. Anti-proliferative effects of gamma-tocotrienol on mammary tumour cells are associated with suppression of cell cycle progression.
    Samant GV; Wali VB; Sylvester PW
    Cell Prolif; 2010 Feb; 43(1):77-83. PubMed ID: 19922488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
    Wali VB; Bachawal SV; Sylvester PW
    Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product.
    Elangovan S; Hsieh TC; Wu JM
    Anticancer Res; 2008; 28(5A):2641-7. PubMed ID: 19035289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
    Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
    Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells.
    Parajuli P; Tiwari RV; Sylvester PW
    Cell Prolif; 2015 Aug; 48(4):421-35. PubMed ID: 26096843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells.
    Samant GV; Sylvester PW
    Cell Prolif; 2006 Dec; 39(6):563-74. PubMed ID: 17109639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. γ-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells.
    Ayoub NM; Bachawal SV; Sylvester PW
    Cell Prolif; 2011 Dec; 44(6):516-26. PubMed ID: 21973114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I; Polyak K; Iavarone A; Massagué J
    Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase C(alpha) activation.
    Sylvester PW; McIntyre BS; Gapor A; Briski KP
    Cell Prolif; 2001 Dec; 34(6):347-57. PubMed ID: 11736999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of energy restriction: effects of corticosterone on cell growth, cell cycle machinery, and apoptosis.
    Jiang W; Zhu Z; Bhatia N; Agarwal R; Thompson HJ
    Cancer Res; 2002 Sep; 62(18):5280-7. PubMed ID: 12234997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of G1 and G2/M cell cycle arrests by the dietary compound 3,3'-diindolylmethane in HT-29 human colon cancer cells.
    Choi HJ; Lim DY; Park JH
    BMC Gastroenterol; 2009 May; 9():39. PubMed ID: 19480695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-Tocotrienol-induced autophagy in malignant mammary cancer cells.
    Tiwari RV; Parajuli P; Sylvester PW
    Exp Biol Med (Maywood); 2014 Jan; 239(1):33-44. PubMed ID: 24231340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.
    Landis MW; Pawlyk BS; Li T; Sicinski P; Hinds PW
    Cancer Cell; 2006 Jan; 9(1):13-22. PubMed ID: 16413468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
    Bachawal SV; Wali VB; Sylvester PW
    BMC Cancer; 2010 Mar; 10():84. PubMed ID: 20211018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.